FGFR2 and infection: While BTC can delineate into actionable subtypes for therapy (FGFR2 fusion or IDH mutations), improved understanding of immune differences in BTC may aid design of immunotherapy trials.63,64 Previous research has pointed to tissue-specific influences on inflammation and immune response to disease and infection.